NCT01887548

Brief Summary

Quality of life is recommended as one of essential parameters to evaluate treatment effect and clinical outcome in patients with Crohn's disease (CD). Recent studies reported that several disease-unrelated variables may affect quality of life in CD patients. This study is dedicated to investigate the influence of various personality traits on quality of life, and whether or not they should be taken into account when evaluating clinical outcomes in patients with CD.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2012

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2012

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

June 19, 2013

Completed
8 days until next milestone

First Posted

Study publicly available on registry

June 27, 2013

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2013

Completed
Last Updated

June 27, 2013

Status Verified

June 1, 2013

Enrollment Period

1.8 years

First QC Date

June 19, 2013

Last Update Submit

June 24, 2013

Conditions

Keywords

Crohn's diseaseinflammatory bowel diseasequality of lifepersonalityneuroticism

Outcome Measures

Primary Outcomes (1)

  • IBDQ

    Inflammatory Bowel Disease Questionnaires (IBDQ) is the most widely used and validated disease-specific instrument, which contains 32 items and assesses four aspects (subscales) of quality of life: emotional function (12 items), social function (5 items), bowel function (10 items) and systemic symptom (5 items).

    one week

Secondary Outcomes (3)

  • Eysenck Personality Inventory (EPI)

    one week

  • Hospital Anxiety and Depression Scale (HADS)

    one week

  • Buss Perry Aggregation (BPA) questionnaire

    one week

Study Arms (2)

Active CD

EXPERIMENTAL

Patients whose CDAI score \>150 points would be enrolled in this group.

Other: Personality Traits Questionnaires

Quiescent CD

ACTIVE COMPARATOR

Patients whose CDAI score ≤150 points would be enrolled in this group.

Other: Personality Traits Questionnaires

Interventions

Patients are required to fill out several personality traits questionnaires. The following personality traits scores would be collected: IBDQ, IBDQ-Emotional function score, IBDQ-Social function score, IBDQ-Bowel function score, IBDQ-Systemic symptom score, Neuroticism score, Lie (social conformity/desirability) score, Hospital anxiety score, Hospital depression score, Buss-Perry score, PA (physical aggression) score, VA (verbal aggression) score, A (anger) score, H (hostility) score.

Active CDQuiescent CD

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years old
  • a definite diagnosis of CD

You may not qualify if:

  • current or previous mental disorders
  • receiving or once received psychotherapy
  • presence of major medical conditions (such as necessity of an operation)
  • chronic disease history other than inflammatory bowel disease
  • unwilling to participate in or cannot accomplish current study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Surgery, Jinling Hospital

Nanjing, Jiangsu, 210002, China

Location

MeSH Terms

Conditions

Crohn DiseaseInflammatory Bowel Diseases

Condition Hierarchy (Ancestors)

GastroenteritisGastrointestinal DiseasesDigestive System DiseasesIntestinal Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Vice president of department of surgery, Jinling Hospital

Study Record Dates

First Submitted

June 19, 2013

First Posted

June 27, 2013

Study Start

March 1, 2012

Primary Completion

December 1, 2013

Study Completion

December 1, 2013

Last Updated

June 27, 2013

Record last verified: 2013-06

Locations